Anti-Therapeutic Action: confusion

Simultaneous cannabis and psychedelic use among festival and concert attendees in Colorado: characterizing enhancement and adverse reactions using mixed methods

This study surveyed music festival and concert attendees in Colorado about their experiences using cannabis and psychedelics together. Researchers found that most people reported cannabis made their psychedelic experience better by reducing anxiety, enhancing mood, or intensifying effects. Only a small percentage experienced negative effects like increased anxiety or confusion. The study suggests cannabis may help people manage difficult psychedelic trips, though more research is needed to understand how different types and amounts of cannabis affect outcomes.

Read More »

Development of the Japanese version of the Challenging Experience Questionnaire

Researchers have translated an important measurement tool called the Challenging Experience Questionnaire into Japanese. This tool helps doctors and researchers measure difficult feelings like fear and anxiety that people sometimes experience when taking psilocybin mushrooms as part of therapy. Having this questionnaire available in Japanese is important because it allows Japanese patients and researchers to participate in psychedelic research and understand these experiences better.

Read More »

Nature’s Own Pharmacy: Mushroom-Based Chemical Scaffolds and Their Therapeutic Implications

This comprehensive review explores how mushrooms can be used as natural medicines. Various mushroom species contain powerful compounds that can fight cancer, boost immunity, reduce inflammation, and treat infections. The paper details 15 important medicinal mushrooms and their therapeutic uses, showing that mushrooms are indeed a nature’s pharmacy with significant potential for treating many diseases.

Read More »

Current situation regarding psychedelics and magic mushroom in Korea

This article reviews the current status of psychedelic mushrooms and their potential medical uses in Korea. Several wild mushroom species containing psilocybin have been identified in Korea and can cause hallucinations and other nervous system effects lasting a few hours. While psychedelics show promise for treating depression and anxiety, Korea currently classifies them as controlled substances, and only approved clinical trials can be conducted with government permission.

Read More »

Neurotoxicity associated with the medicinal mushroom product-Diamond Shruumz: A case report

A 17-year-old girl became severely ill after eating a chocolate bar containing a medicinal mushroom product that was contaminated with muscimol, a toxic compound from poisonous mushrooms. She experienced confusion, uncontrollable muscle jerks, dilated pupils, and excessive drooling, requiring hospitalization and temporary breathing assistance. Though her symptoms resolved within 8 hours and she recovered fully, this case highlights the serious danger of unregulated mushroom supplements that can be contaminated with deadly toxins.

Read More »
Scroll to Top